| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.0024 | 1 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | -0.00091 | 1 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | 0.00071 | 1 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00068 | 1 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.00059 | 1 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |